Results 141 to 150 of about 156,135 (207)

A Prospective Cohort Study of Hard‐to‐Heal Chronic Foot and Leg Wounds Followed for up to 20 Weeks After Initiation of ReGenerating Tissue Agents (RGTA) Technology as an Add‐on to Optimal Local Care

International Wound Journal, Volume 23, Issue 10, October 2026.
ABSTRACT ReGenerating Tissue Agents (RGTA, trade name CACIPLIQ20) contain a structural analogue of heparan sulfates (HSs) that promotes tissue regeneration in hard‐to‐heal chronic wounds resistant to the best standard of care for 6 months or longer.
Serge Ynesta, Marion Mourgues, Chloé Geri, Martin Inizan, Denis Barritault, Frédéric Sedel, Jean‐Charles Kerihuel, Luc Téot   +7 more
wiley   +1 more source

Routine CYP2C19 Genotyping, Antiplatelet Prescription Changes, and Clinical Outcomes After PCI in Chinese Patients With Coronary Heart Disease: A Single-Center Retrospective Study. [PDF]

Cardiol Res Pract
Niu D, Zhang M, Guan H.
europepmc   +1 more source

Indobufen-based dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and network meta-analysis. [PDF]

J Int Med Res
Gopinath A, Heo J, Fatima A, Yerrajonna A, George H, Mohd R, Turjman T, Azuwike UB, Bien-Aimé DPC, Lefevre JAS, Rech L, Asfaw MD, Ekumbal JR, Dalil L, Khawar MMH.   +14 more
europepmc   +1 more source

Frequencies of <i>CYP2C19</i> Polymorphisms in Mexican Mestizo Patients with Coronary or Cerebral Atherosclerosis and Their Association with Residual Platelet Activity on Clopidogrel Treatment. [PDF]

Biomedicines
Izaguirre-Ávila R, Villegas-Torres B, de La Rosa EC, Fernández-López JC, Ayala-Guerrero JM, Merlín-González EV, Lerma C.   +6 more
europepmc   +1 more source

Prasugrel 5 mg in acute coronary syndromes: indications and clinical outcomes. [PDF]

Rev Assoc Med Bras (1992)
Tanajura LFL, Delamain JH, Labrunie A, Souza GBN, Tanajura LGO.   +4 more
europepmc   +1 more source

Comparative evaluation of anti-inflammatory and antioxidant effects of prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention: A prospective cohort study. [PDF]

Indian J Pharmacol
Vinayagam S, Mittal N, Kumar A, Kumawat M, Parmar A, Kalra V, Jebaraj J.   +6 more
europepmc   +1 more source

Severe Cholestatic Liver Injury Associated With Clopidogrel: A Rare Case of Drug-Induced Liver Injury. [PDF]

ACG Case Rep J
Yuen J, Panuncillon P, Ebiai R, Memon A.
europepmc   +1 more source

Potential alternatives in treatment of kawasaki disease to reduce the extremely rare risk of reye syndrome. [PDF]

Front Pediatr
Johnson EJ, Moser JD, Buehrer BS, Ngo K, Raina R.   +4 more
europepmc   +1 more source

The impact of concomitant use of rosuvastatin or atorvastatin plus clopidogrel on the platelet inhibition and clinical outcomes in acute large-vessel minor stroke or TIA: A randomized controlled multi-center trial, the ROCATIS-1 trial. [PDF]

Ther Adv Neurol Disord
Zeinhom MG, Sayed Ismaiel MG, Khalil MFE, Elmesallami AG, Khalil GAE, Akl AZO, Georgy SS, Abbas AA, Kerolos YSS, Abdeldayem SM, Khalil EHE, Mostafa E, Youssif TYO, Egila AAE, Alkhalefeh AG, Hassan AM, Zedan TS, Ghoname AE, Mahmoud ELA, Mushtaque A, Abdelkhalek AM, Ghazi EAA, Ahmed SR.   +22 more
europepmc   +1 more source

Assessment of Pharmacokinetic Interaction and Clinical Efficacy of Clopidogrel Co-administered with Ilaprazole. [PDF]

Clin Pharmacol Drug Dev
N D, A P, T M V, N A R.
europepmc   +1 more source